BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 14190338)

  • 1. THE EFFECT OF D-LYSERGIC ACID DIETHYLAMIDE TARTRATE (LSD-25) AND D-2-BROMO LYSERGIC ACID TARTRATE (BOL-148) ON SPECIFIC CHOLINESTERASE AND MONOAMINE OXIDASE OF RAT LIVER AS POSSIBLE FACTORS IN THE MECHANISM OF HALLUCINATION. A HISTOCHEMICAL STUDY.
    NANDY K; SHANTHAVEERAPPA TR; BOURNE GH
    Acta Histochem; 1964 Apr; 17():259-67. PubMed ID: 14190338
    [No Abstract]   [Full Text] [Related]  

  • 2. HISTOCHEMICAL STUDIES ON THE MECHANISM OF ACTION OF THE HALLUCINOGENS D-LYSERGIC ACID DIETHYLAMIDE TARTRATE (LSD-25) AND D-2-BROMO-LYSERGIC ACID TARTRATE (BOL-148) IN RAT BRAIN.
    SHANTHAVEERAPPA TR; NANDY K; BOURNE GH
    Acta Neuropathol; 1963 Sep; 3():29-39. PubMed ID: 14197655
    [No Abstract]   [Full Text] [Related]  

  • 3. THE EFFECTS OF D-LYSERGIC ACID DIETHYLAMIDE TARTRATE (LSD-25) ON THE CHOLINESTERASES AND MONOAMINE OXIDASE IN THE SPINAL CORD: A POSSIBLE FACTOR IN THE MECHANISM OF HALLUCINATION.
    NANDY K; BOURNE GH
    J Neurol Neurosurg Psychiatry; 1964 Jun; 27(3):259-67. PubMed ID: 14175297
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25).
    ISBELL H; MINER EJ; LOGAN CR
    Psychopharmacologia; 1959 Nov; 1():109-16. PubMed ID: 14405871
    [No Abstract]   [Full Text] [Related]  

  • 5. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of 5-hydroxytryptamine antidiuresis in rats by 2-bromlysergic acid diethylamide tartrate and 1-methyl-lysergic acid butanolamide.
    CHODERA A
    J Pharm Pharmacol; 1963 Jun; 15():386-9. PubMed ID: 14020952
    [No Abstract]   [Full Text] [Related]  

  • 7. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THE SYNTHESIS OF ARYLALKYLAMINOPROPIONAMIDE ANALOGS OF LYSERGIC ACID DIETHYLAMIDE AND THEIR EFFECT UPON ISOLATED CHOLINESTERASE SYSTEMS. II.
    LASSLO A; WALLER PD; EPPERSON GJ
    J Med Chem; 1963 Jan; 6():26-8. PubMed ID: 14174025
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats].
    Loew DM; Depoortere H; Vigouret JM
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):394-5. PubMed ID: 4326420
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of psychological effects of d-lysergic acid diethylamide (LSD 25) by its 2-brom derivative (BOL 148).
    GINZEL KH; MAYER-GROSS W
    Nature; 1956 Jul; 178(4526):210. PubMed ID: 13348662
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of mescaline and lysergic acid (d-LSD-25).
    HOCH PH; CATTELL JP; PENNES HH
    Am J Psychiatry; 1952 Feb; 108(8):579-84. PubMed ID: 14903183
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychopharmacological studies of lysergic acid diethylamide (LSD-25) intoxication; effects of premedication with BOL-128 (2-bromo-d-lysergic acid diethylamide), mescaline, atropine, amobarbital, and chlorpromazine.
    CLARK LD; BLISS EL
    AMA Arch Neurol Psychiatry; 1957 Dec; 78(6):653-5. PubMed ID: 13478222
    [No Abstract]   [Full Text] [Related]  

  • 13. ANTAGONISM OF LYSERGIC ACID DIETHYLAMIDE (LSD)-INDUCED HYPERGLYCEMIA.
    ELDER JT
    Int J Neuropharmacol; 1964 Jul; 3():295-300. PubMed ID: 14333281
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of lysergic acid diethylamide (LSD-25) upon the histochemical reactions for cholinesterase in the central nervous system.
    GOLDBERGER M
    Acta Anat (Basel); 1961; 46():185-91. PubMed ID: 13899716
    [No Abstract]   [Full Text] [Related]  

  • 15. LSD-25 ACTION IN NORMAL SUBJECTS TREATED WITH A MONOAMINE OXIDASE INHIBITOR.
    RESNICK O; KRUS DM; RASKIN M
    Life Sci (1962); 1964 Nov; 3():1207-14. PubMed ID: 14231769
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LYSERGIC ACID DIETHYLAMIDE (LSD-25). XXXV. COMPARISON OF EFFECT ON SIAMESE FIGHTING FISH AND GOLDFISH.
    GETTNER HH; ROLO A; ABRAMSON HA
    J Psychol; 1964 Jul; 58():57-63. PubMed ID: 14163636
    [No Abstract]   [Full Text] [Related]  

  • 18. ANTIMESCALINE PROPERTIES OF SOME LYSERGIC ACID DERIVATIVES.
    BORSY J; HUSZTI Z; FEKETE M
    Int J Neuropharmacol; 1963 Dec; 2():273-7. PubMed ID: 14119487
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentiation of substance P by lysergic acid diethvlamide in vivo.
    KRIVOY WA
    Br J Pharmacol Chemother; 1961 Jun; 16(3):253-6. PubMed ID: 13754427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EXPERIMENTAL HYPERTHYROIDISM INDUCED BY CHRONIC LYSERGIC ACID BUTANOLAMIDE TREATMENT.
    MESS B; SZANTO L
    Acta Physiol Acad Sci Hung; 1964; 25():83-8. PubMed ID: 14196573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.